Device for noninvasive brain biopsies via blood draw moves closer to market approval - The Source

A device aimed at enabling physicians to perform noninvasive blood-based biopsies in adults with brain tumors has received Food and Drug Administration “Breakthrough Device” designation. The device includes Washington University in St. Louis technology.

Related Keywords

Hong Chen , Ericc Leuthardt , Drug Administration , Department Of Neurosurgery , Mckelvey School Of Engineering , Washington University In St , Division Of Neurotechnology , Washington University , Cordance Medical Inc , School Of Medicine , Mountain View , Shi Hui Huang Professor , Washington University School , Mckelvey School , Cordance Medical ,